NASDAQ:HOLX - Nasdaq - US4364401012 - Common Stock - Currency: USD
64.49
+0.17 (+0.26%)
The current stock price of HOLX is 64.49 USD. In the past month the price decreased by -8.78%. In the past year, price decreased by -15.31%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
SYK | STRYKER CORP | 31.4 | 145.92B | ||
MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
DXCM | DEXCOM INC | 53.81 | 34.68B | ||
RMD | RESMED INC | 26.21 | 34.03B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. The company is headquartered in Marlborough, Massachusetts. The company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Diagnostics segment offers a range of diagnostic products, which are used to aid in the screening and diagnosis of human diseases. Breast Health segment offers a portfolio of solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment. The company also offers wireless breast surgery localization and lymphatic tracing solutions. GYN Surgical segment products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Fluent fluid management system and Acessa ProVu laparoscopic radiofrequency ablation system. Skeletal Health segment products include Horizon DXA Systems and Fluoroscan Insight FD.
HOLOGIC INC
250 Campus Drive
Marlborough MASSACHUSETTS 01752 US
CEO: STEPHEN P. MACMILLAN
Employees: 6990
Company Website: https://www.hologic.com/
Investor Relations: https://investors.hologic.com
Phone: 15082632900
The current stock price of HOLX is 64.49 USD. The price increased by 0.26% in the last trading session.
The exchange symbol of HOLOGIC INC is HOLX and it is listed on the Nasdaq exchange.
HOLX stock is listed on the Nasdaq exchange.
28 analysts have analysed HOLX and the average price target is 87.51 USD. This implies a price increase of 35.7% is expected in the next year compared to the current price of 64.49. Check the HOLOGIC INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
HOLOGIC INC (HOLX) has a market capitalization of 14.47B USD. This makes HOLX a Large Cap stock.
HOLOGIC INC (HOLX) currently has 6990 employees.
HOLOGIC INC (HOLX) has a support level at 64.16 and a resistance level at 70.29. Check the full technical report for a detailed analysis of HOLX support and resistance levels.
The Revenue of HOLOGIC INC (HOLX) is expected to grow by 3.54% in the next year. Check the estimates tab for more information on the HOLX EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
HOLX does not pay a dividend.
HOLOGIC INC (HOLX) will report earnings on 2025-04-30, after the market close.
The PE ratio for HOLOGIC INC (HOLX) is 15.62. This is based on the reported non-GAAP earnings per share of 4.13 and the current share price of 64.49 USD. Check the full fundamental report for a full analysis of the valuation metrics for HOLX.
The outstanding short interest for HOLOGIC INC (HOLX) is 2.66% of its float. Check the ownership tab for more information on the HOLX short interest.
ChartMill assigns a fundamental rating of 6 / 10 to HOLX. HOLX scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
Over the last trailing twelve months HOLX reported a non-GAAP Earnings per Share(EPS) of 4.13. The EPS increased by 6.99% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 18.42% | ||
ROA | 8.52% | ||
ROE | 15.59% | ||
Debt/Equity | 0.52 |
ChartMill assigns a Buy % Consensus number of 74% to HOLX. The Buy consensus is the average rating of analysts ratings from 28 analysts.
For the next year, analysts expect an EPS growth of 6.65% and a revenue growth 3.54% for HOLX